http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007061868-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_09fc02a407043ca0a10e2dbe5fcb6159
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0852e6d52784f9f538f4bca78977609e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4c56c12d195c1e0802a7a9ea228659c4
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-13
filingDate 2006-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a360975c375d2995669c1943bce24402
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04f808661cdf4a7949a954607a63d280
publicationDate 2008-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2007061868-A3
titleOfInvention Treatment of stereotypic, self-injurious and compulsive behaviors using specific serotonin reuptake inhibitors and antagonists of nmda receptors
abstract A combination of a specific serotonin reuptake inhibitor (SSRI) and an NMDA receptor antagonist can be used in methods of treatment, for reducing the frequency of stereotypic behaviors in animals and for reducing the frequency of analogous compulsive behaviors in humans, for example, those that have been said to be a manifestation of, or related to, obsessive-compulsive disorder.
priorityDate 2005-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006034187-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002035105-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005000216-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0002551-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394200
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5202

Total number of triples: 27.